Devalaraja; Madhav Narasimha
Patent Applications and Registrations
Patent applications and USPTO patent grants for Devalaraja; Madhav Narasimha.The latest application filed is for "antibodies to m-csf".
- Devalaraja; Madhav Narasimha - Ann Arbor MI
- Devalaraja; Madhav Narasimha - Gaithersburg MD
| Patent | Date |
|---|---|
| Antibodies To M-csf App 20190202905 - Bedian; Vahe ; et al. | 2019-07-04 |
| Antibodies to M-CSF Grant 10,280,219 - Bedian , et al. | 2019-05-07 |
| Antibodies To M-csf App 20170275354 - Bedian; Vahe ; et al. | 2017-09-28 |
| Antibodies to M-CSF Grant 9,718,883 - Bedian , et al. August 1, 2 | 2017-08-01 |
| Antibodies To M-csf App 20160244519 - Bedian; Vahe ; et al. | 2016-08-25 |
| Antibodies To Il-6 And Their Uses App 20150203574 - Rajpal; Arvind ; et al. | 2015-07-23 |
| Antibodies to IL-6 and their uses Grant 8,846,037 - Rajpal , et al. September 30, 2 | 2014-09-30 |
| Antibodies To Il-6 And Their Uses App 20130280266 - Rajpal; Arvind ; et al. | 2013-10-24 |
| Antibodies to IL-6 and their uses Grant 8,436,158 - Rajpal , et al. May 7, 2 | 2013-05-07 |
| Antibodies To M-csf App 20120244167 - Bedian; Vahe ; et al. | 2012-09-27 |
| Nucleic acid molecules encoding antibodies to M-CSF Grant 8,188,249 - Bedian , et al. May 29, 2 | 2012-05-29 |
| Antibodies To M-csf App 20100247545 - Bedian; Vahe ; et al. | 2010-09-30 |
| Methods of treating arthritic conditions with antibodies to M-CSF Grant 7,728,113 - Bedian , et al. June 1, 2 | 2010-06-01 |
| Antibodies to M-CSF Grant 7,592,430 - Bedian , et al. September 22, 2 | 2009-09-22 |
| Antibodies to M-CSF App 20080254032 - Bedian; Vahe ; et al. | 2008-10-16 |
| Antibodies to M-CSF Grant 7,326,414 - Bedian , et al. February 5, 2 | 2008-02-05 |
| Antibodies to M-CSF App 20060153850 - Bedian; Vahe ; et al. | 2006-07-13 |
| Method of treating or inhibiting neutrophil chemotaxis by administering a MEK inhibitor Grant 6,972,298 - Baragi , et al. December 6, 2 | 2005-12-06 |
| Antibodies to M-CSF App 20050059113 - Bedian, Vahe ; et al. | 2005-03-17 |
| Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor App 20030055095 - Baragi, Vijaykumar M. ; et al. | 2003-03-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 